Sanne G S Verberk Selected Research

CD40 Ligand (CD40L)

1/2023

Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory state.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanne G S Verberk Research Topics

Disease

3	Inflammation (Inflammations) 12/2021 - 09/2020
2	Atherosclerotic Plaque (Atheroma) 01/2023 - 12/2020
1	Cognitive Dysfunction 04/2024
1	Neuroinflammatory Diseases 04/2024
1	Demyelinating Diseases (Demyelinating Disease) 12/2023
1	Hypercholesterolemia 12/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Atherosclerosis 12/2021
1	Neoplasms (Cancer) 06/2021
1	Carcinogenesis 06/2021
1	Peritonitis 01/2021

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 12/2021 - 12/2020
3	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 12/2021 - 12/2020
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 12/2023
1	CholesterolIBA 12/2023
1	CuprizoneIBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2023
1	CD40 Ligand (CD40L)IBA 01/2023
1	LigandsIBA 01/2023
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 06/2021
1	PlasticsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	EndotoxinsIBA 01/2021
1	Succinic Acid (Succinate)IBA 09/2020

Therapy/Procedure

2	Therapeutics 12/2021 - 06/2021